While TGFβ acts as a tumor suppressant in normal cells by inhibiting cell growth, in cancer cells, the TGFβ/SMAD axis is modified resulting in impaired mediation of growth arrest [45]. The gene discussed is TGFB1; the disease is neoplasm.